Europe’s Food Safety Authority (EFSA) rules scientific evidence pointing to a white kidney bean extract’s link with body weight reduction as “insufficient,” after the applicant cites application process inconsistencies.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
Endo Sport launches the UK’s first CBD-infused sports drink that harnesses the active ingredient’s anti-inflammatory properties to help reduce post-exercise muscle soreness and aid recovery.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
Indena is using its proprietary phytosome delivery system, to study a more bioavailable formulation of quercetin, with preliminary clinical evidences in allergy control.
Cannabis Trades Association (CTA) members will not submit a Novel Foods application for its cannabis containing products as it cites the uncertainty of the regulation’s scope as the main reason.
'Glowing' skin is a key aim for skin care shoppers and 98% of them believe that good nutrition is necessary to achieving this, according to a survey by Lycored.
The winner of the 2019 NutraIngredients-Asia award for Ingredient of the Year for Healthy Ageing, Pharmactive Biotech Products, has highlighted South East Asia as one of its biggest growth opportunities.
Italy’s Competition Authority (AGCM) fines lifestyle firm Life120 Italia almost €300,000 for repeating banned commercial practices that include referencing products with unproven therapeutic effects.
Givaudan is exploring the idea of personalised nutricosmetic products with its microbiome analysis system designed to tailor products to consumer’s bacterial skin communities.
Acute consumption of a flavonoid-rich wild blueberry drink may improve memory and attentional aspects of executive function in healthy children, suggests a study from the UK.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
Belgium’s Federal Agency for the Safety of the Food Chain (FASFC) is recalling a popular fat-burning supplement over concerns about the product’s caffeine content.
